rs149496322
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 1P and 10B. PP2BP4BP6BS1BS2
The NM_001376.5(DYNC1H1):c.10522C>A(p.Leu3508Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000142 in 1,614,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L3508L) has been classified as Likely benign.
Frequency
Consequence
NM_001376.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYNC1H1 | NM_001376.5 | c.10522C>A | p.Leu3508Ile | missense_variant | 55/78 | ENST00000360184.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYNC1H1 | ENST00000360184.10 | c.10522C>A | p.Leu3508Ile | missense_variant | 55/78 | 1 | NM_001376.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000190 AC: 29AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251378Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135870
GnomAD4 exome AF: 0.000137 AC: 201AN: 1461830Hom.: 0 Cov.: 31 AF XY: 0.000136 AC XY: 99AN XY: 727208
GnomAD4 genome AF: 0.000190 AC: 29AN: 152366Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74506
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 12, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 13, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | DYNC1H1: PP2, PP3, BS2 - |
Charcot-Marie-Tooth disease axonal type 2O;C3281202:Intellectual disability, autosomal dominant 13;C5780022:Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Apr 14, 2022 | This variant has been reported in the literature in 1 individual with clinical suspicion of Charcot Marie Tooth disease (Volodarsky 2021 PMID:32376792). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.02% (19/68042) (https://gnomad.broadinstitute.org/variant/14-102034084-C-A?dataset=gnomad_r3)). This variant is present in ClinVar (Variation ID:380403). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Intellectual disability, autosomal dominant 13 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Oct 02, 2019 | - - |
Charcot-Marie-Tooth disease axonal type 2O Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 24, 2017 | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at